» Articles » PMID: 19400268

Opportunities and Challenges of Developing Peptide Drugs in the Pharmaceutical Industry

Overview
Date 2009 Apr 30
PMID 19400268
Citations 14
Authors
Affiliations
Soon will be listed here.
Citing Articles

Molecular Integrative Study on Inhibitory Effects of Pentapeptides on Polymerization and Cell Toxicity of Amyloid-β Peptide (1-42).

Ye L, Ajuyo N, Wu Z, Yuan N, Xiao Z, Gu W Curr Issues Mol Biol. 2024; 46(9):10160-10179.

PMID: 39329958 PMC: 11431437. DOI: 10.3390/cimb46090606.


Secretomic changes of amyloid beta peptides on Alzheimer's disease related proteins in differentiated human SH-SY5Y neuroblastoma cells.

Roytrakul S, Jaresitthikunchai J, Phaonakrop N, Charoenlappanit S, Thaisakun S, Kumsri N PeerJ. 2024; 12:e17732.

PMID: 39035166 PMC: 11260076. DOI: 10.7717/peerj.17732.


Molecular Integrative Analysis of the Inhibitory Effects of Dipeptides on Amyloid β Peptide 1-42 Polymerization.

Yuan N, Ye L, Sun Y, Wu H, Xiao Z, Fu W Int J Mol Sci. 2023; 24(8).

PMID: 37108834 PMC: 10141046. DOI: 10.3390/ijms24087673.


Ameliorating Fibrosis in Murine and Human Tissues with END55, an Endostatin-Derived Fusion Protein Made in Plants.

Mlakar L, Garrett S, Watanabe T, Sanderson M, Nishimoto T, Heywood J Biomedicines. 2022; 10(11).

PMID: 36359382 PMC: 9687961. DOI: 10.3390/biomedicines10112861.


Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease.

Aillaud I, Funke S Cell Mol Neurobiol. 2022; 43(3):951-961.

PMID: 35596819 PMC: 10006036. DOI: 10.1007/s10571-022-01230-7.